Literature DB >> 27660553

Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.

Asma Ashraf1, Andreas V Hadjinicolaou2, Carolyn Doree3, Sally Hopewell4, Marialena Trivella5, Lise J Estcourt6.   

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To compare a therapeutic-only versus prophylactic platelet transfusion policy for people with myelodysplasia, inherited or acquired aplastic anaemia, and other congenital bone marrow failure disorders.

Entities:  

Year:  2016        PMID： 27660553      PMCID： PMC5027963          DOI： 10.1002/14651858.CD012342

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


  53 in total

1.  Guidelines for the diagnosis and management of adult aplastic anaemia.

Authors:  Sally B Killick; Nick Bown; Jamie Cavenagh; Inderjeet Dokal; Theodora Foukaneli; Anita Hill; Peter Hillmen; Robin Ireland; Austin Kulasekararaj; Ghulam Mufti; John A Snowden; Sujith Samarasinghe; Anna Wood; Judith C W Marsh
Journal:  Br J Haematol       Date:  2015-11-16       Impact factor: 6.998

Review 2.  The case of the misleading funnel plot.

Authors:  Joseph Lau; John P A Ioannidis; Norma Terrin; Christopher H Schmid; Ingram Olkin
Journal:  BMJ       Date:  2006-09-16

3.  Haematological cancer: Prophylactic platelet transfusion is frequently not necessary.

Authors:  Charles A Schiffer
Journal:  Nat Rev Clin Oncol       Date:  2013-07-02       Impact factor: 66.675

4.  Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.

Authors:  M K Parmar; V Torri; L Stewart
Journal:  Stat Med       Date:  1998-12-30       Impact factor: 2.373

Review 5.  Thrombocytopenia: mechanisms and management of defects in platelet production.

Authors:  S J Slichter; L A Harker
Journal:  Clin Haematol       Date:  1978-10

6.  Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia.

Authors:  J Gmür; J Burger; U Schanz; J Fehr; A Schaffner
Journal:  Lancet       Date:  1991-11-16       Impact factor: 79.321

7.  The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

Authors:  P Rebulla; G Finazzi; F Marangoni; G Avvisati; L Gugliotta; G Tognoni; T Barbui; F Mandelli; G Sirchia
Journal:  N Engl J Med       Date:  1997-12-25       Impact factor: 91.245

Review 8.  Platelet transfusion refractoriness.

Authors:  Eldad Hod; Joseph Schwartz
Journal:  Br J Haematol       Date:  2008-05-28       Impact factor: 6.998

9.  Myelodysplastic syndromes: incidence and survival in the United States.

Authors:  Xiaomei Ma; Monique Does; Azra Raza; Susan T Mayne
Journal:  Cancer       Date:  2007-04-15       Impact factor: 6.860

10.  Practical methods for incorporating summary time-to-event data into meta-analysis.

Authors:  Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes
Journal:  Trials       Date:  2007-06-07       Impact factor: 2.279
View more
  1 in total

Review 1.  Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.

Authors:  Reem Malouf; Asma Ashraf; Andreas V Hadjinicolaou; Carolyn Doree; Sally Hopewell; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2018-05-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.